Korea Unveils 5-Year Roadmap To Nurture Domestic Industry
Executive Summary
South Korea’s five-year blueprint to nurture the pharma industry outlines a string of measures including plans to set up smart clinical trial platforms, use artificial intelligence for new drug R&D, invest in public purpose pharma R&D and improve drug approval and reimbursement systems.